Cross Sectional Study of Use of Alternative Medicines in Chinese Cancer Patients

Jacqueline Ming Liu, Hshun Chie Chu, Yung Hsin Chin, Yuh Min Chen, Ruey Kuen Hsieh, Tzeon Jye Chiou, Jacqueline Whang-Peng

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The aim of this study was to ascertain the prevalence of alternative medicine consumption in Chinese cancer patients on active conventional treatment. A cross sectional survey of 100 consecutive advanced cancer patients admitted to a cancer clinical trial referral unit were personally interviewed by their assigned oncology research nurse using a specially designed questionnaire. The results showed that 64% of our patients used indigenous Chinese medication. In all age groups except the over-70s (P = 0.043), >50% took such medication, more female (76%) than male (57.6%) patients (P = 0.323). Patients of all educational levels (P = 0.062) and religious backgrounds (P = 0.08) consumed alternative medicines. Duration of alternative medication consumption was less than three months in 50% of patients, with costs between US$40 and 2000/month for 70% of patients. Reasons cited for alternative medication consumption was hope that it might be of some benefit to their well being or disease control, and maybe even result in a miracle cure. Sources of advice on medication were mostly from strangers (by word of mouth), family, friends, the media, and infrequently from qualified professional Chinese doctors. Reasons for discontinuing such treatment were mostly given as lack of positive effect. In conclusion, Chinese cancer patients, willingly, rampantly and non-selectiveiy seek out and consume alternative medications, with almost total ignorance of the medication consumed, oblivious to any potential side effects, and with little subjective benefit.

Original languageEnglish
Pages (from-to)37-41
Number of pages5
JournalJapanese Journal of Clinical Oncology
Volume27
Issue number1
Publication statusPublished - Dec 1 1997
Externally publishedYes

Fingerprint

Complementary Therapies
Cross-Sectional Studies
Neoplasms
Hope
Referral and Consultation
Age Groups
Nurses
Clinical Trials
Costs and Cost Analysis
Therapeutics
Research

Keywords

  • Alternative medicine
  • Chinese cancer patients
  • Cross sectional study
  • Herbs

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Liu, J. M., Chu, H. C., Chin, Y. H., Chen, Y. M., Hsieh, R. K., Chiou, T. J., & Whang-Peng, J. (1997). Cross Sectional Study of Use of Alternative Medicines in Chinese Cancer Patients. Japanese Journal of Clinical Oncology, 27(1), 37-41.

Cross Sectional Study of Use of Alternative Medicines in Chinese Cancer Patients. / Liu, Jacqueline Ming; Chu, Hshun Chie; Chin, Yung Hsin; Chen, Yuh Min; Hsieh, Ruey Kuen; Chiou, Tzeon Jye; Whang-Peng, Jacqueline.

In: Japanese Journal of Clinical Oncology, Vol. 27, No. 1, 01.12.1997, p. 37-41.

Research output: Contribution to journalArticle

Liu, JM, Chu, HC, Chin, YH, Chen, YM, Hsieh, RK, Chiou, TJ & Whang-Peng, J 1997, 'Cross Sectional Study of Use of Alternative Medicines in Chinese Cancer Patients', Japanese Journal of Clinical Oncology, vol. 27, no. 1, pp. 37-41.
Liu JM, Chu HC, Chin YH, Chen YM, Hsieh RK, Chiou TJ et al. Cross Sectional Study of Use of Alternative Medicines in Chinese Cancer Patients. Japanese Journal of Clinical Oncology. 1997 Dec 1;27(1):37-41.
Liu, Jacqueline Ming ; Chu, Hshun Chie ; Chin, Yung Hsin ; Chen, Yuh Min ; Hsieh, Ruey Kuen ; Chiou, Tzeon Jye ; Whang-Peng, Jacqueline. / Cross Sectional Study of Use of Alternative Medicines in Chinese Cancer Patients. In: Japanese Journal of Clinical Oncology. 1997 ; Vol. 27, No. 1. pp. 37-41.
@article{d8af3dbc2ba748c7a676a4063ba61bc9,
title = "Cross Sectional Study of Use of Alternative Medicines in Chinese Cancer Patients",
abstract = "The aim of this study was to ascertain the prevalence of alternative medicine consumption in Chinese cancer patients on active conventional treatment. A cross sectional survey of 100 consecutive advanced cancer patients admitted to a cancer clinical trial referral unit were personally interviewed by their assigned oncology research nurse using a specially designed questionnaire. The results showed that 64{\%} of our patients used indigenous Chinese medication. In all age groups except the over-70s (P = 0.043), >50{\%} took such medication, more female (76{\%}) than male (57.6{\%}) patients (P = 0.323). Patients of all educational levels (P = 0.062) and religious backgrounds (P = 0.08) consumed alternative medicines. Duration of alternative medication consumption was less than three months in 50{\%} of patients, with costs between US$40 and 2000/month for 70{\%} of patients. Reasons cited for alternative medication consumption was hope that it might be of some benefit to their well being or disease control, and maybe even result in a miracle cure. Sources of advice on medication were mostly from strangers (by word of mouth), family, friends, the media, and infrequently from qualified professional Chinese doctors. Reasons for discontinuing such treatment were mostly given as lack of positive effect. In conclusion, Chinese cancer patients, willingly, rampantly and non-selectiveiy seek out and consume alternative medications, with almost total ignorance of the medication consumed, oblivious to any potential side effects, and with little subjective benefit.",
keywords = "Alternative medicine, Chinese cancer patients, Cross sectional study, Herbs",
author = "Liu, {Jacqueline Ming} and Chu, {Hshun Chie} and Chin, {Yung Hsin} and Chen, {Yuh Min} and Hsieh, {Ruey Kuen} and Chiou, {Tzeon Jye} and Jacqueline Whang-Peng",
year = "1997",
month = "12",
day = "1",
language = "English",
volume = "27",
pages = "37--41",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Cross Sectional Study of Use of Alternative Medicines in Chinese Cancer Patients

AU - Liu, Jacqueline Ming

AU - Chu, Hshun Chie

AU - Chin, Yung Hsin

AU - Chen, Yuh Min

AU - Hsieh, Ruey Kuen

AU - Chiou, Tzeon Jye

AU - Whang-Peng, Jacqueline

PY - 1997/12/1

Y1 - 1997/12/1

N2 - The aim of this study was to ascertain the prevalence of alternative medicine consumption in Chinese cancer patients on active conventional treatment. A cross sectional survey of 100 consecutive advanced cancer patients admitted to a cancer clinical trial referral unit were personally interviewed by their assigned oncology research nurse using a specially designed questionnaire. The results showed that 64% of our patients used indigenous Chinese medication. In all age groups except the over-70s (P = 0.043), >50% took such medication, more female (76%) than male (57.6%) patients (P = 0.323). Patients of all educational levels (P = 0.062) and religious backgrounds (P = 0.08) consumed alternative medicines. Duration of alternative medication consumption was less than three months in 50% of patients, with costs between US$40 and 2000/month for 70% of patients. Reasons cited for alternative medication consumption was hope that it might be of some benefit to their well being or disease control, and maybe even result in a miracle cure. Sources of advice on medication were mostly from strangers (by word of mouth), family, friends, the media, and infrequently from qualified professional Chinese doctors. Reasons for discontinuing such treatment were mostly given as lack of positive effect. In conclusion, Chinese cancer patients, willingly, rampantly and non-selectiveiy seek out and consume alternative medications, with almost total ignorance of the medication consumed, oblivious to any potential side effects, and with little subjective benefit.

AB - The aim of this study was to ascertain the prevalence of alternative medicine consumption in Chinese cancer patients on active conventional treatment. A cross sectional survey of 100 consecutive advanced cancer patients admitted to a cancer clinical trial referral unit were personally interviewed by their assigned oncology research nurse using a specially designed questionnaire. The results showed that 64% of our patients used indigenous Chinese medication. In all age groups except the over-70s (P = 0.043), >50% took such medication, more female (76%) than male (57.6%) patients (P = 0.323). Patients of all educational levels (P = 0.062) and religious backgrounds (P = 0.08) consumed alternative medicines. Duration of alternative medication consumption was less than three months in 50% of patients, with costs between US$40 and 2000/month for 70% of patients. Reasons cited for alternative medication consumption was hope that it might be of some benefit to their well being or disease control, and maybe even result in a miracle cure. Sources of advice on medication were mostly from strangers (by word of mouth), family, friends, the media, and infrequently from qualified professional Chinese doctors. Reasons for discontinuing such treatment were mostly given as lack of positive effect. In conclusion, Chinese cancer patients, willingly, rampantly and non-selectiveiy seek out and consume alternative medications, with almost total ignorance of the medication consumed, oblivious to any potential side effects, and with little subjective benefit.

KW - Alternative medicine

KW - Chinese cancer patients

KW - Cross sectional study

KW - Herbs

UR - http://www.scopus.com/inward/record.url?scp=0031066180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031066180&partnerID=8YFLogxK

M3 - Article

C2 - 9070339

AN - SCOPUS:0031066180

VL - 27

SP - 37

EP - 41

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 1

ER -